|
Dual antiretroviral regimens: A new challenging issue of HIV-infected patient treatment |
|---|---|
| รหัสดีโอไอ | |
| Creator | Ratchayut Harichtee |
| Title | Dual antiretroviral regimens: A new challenging issue of HIV-infected patient treatment |
| Contributor | Nattabhum Kunathikom, Kittiya Jantarathaneewat |
| Publisher | Faculty of Pharmaceutical Sciences KKU, MSU, UBU |
| Publication Year | 2564 |
| Journal Title | Isan Journal ofPharmaceutical Sciences |
| Journal Vol. | 17 |
| Journal No. | 4 |
| Page no. | 30-47 |
| Keyword | Dual antiretroviral regimens, HIV, Treatment Naive, Treatment Experience |
| URL Website | https://tci-thaijo.org/index.php/IJPS |
| Website title | Isan Journal ofPharmaceutical Sciences,IJPS |
| ISSN | 19050852 |
| Abstract | Triple antiretroviral (ARV) regimens are recommended as first-line treatment for HIV infection in various guidelines. However, there are limitations in some HIV-infected patients who have adverse drug reactions or drug interaction with other medication resulting in inability to use these triple regimens. Dual antiretroviral regimens with high efficacy are considered as an alternative choice for both treatment-na?ve and treatment-experienced patients. Dolutegravir and lamivudine are one of dual ARV regimens which have been widely studied and mostly recommended by several guidelines. However, there are some important factors to consider prior to prescribing dual ARV regimen such as viral load, comorbidity, and history of hepatitis B infection. In addition, there have been recent studies about other dual ARV regimens which could be used as alternatives in the near future. This review article aimed to review studies about currently available dual ARV regimens in terms of benefits, disadvantages, efficacy, and safety precaution. |
